drugset / Trial / NCT05061732
Helicobacter Pylori Eradication and Follow-up
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This randomized controlled clinical trial will estimate the eradication efficacy of different therapy for Helicobacter pylori treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.
Timeline
- Start
- 2021-09-30
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Bismuth Potassium Citrate | Unknown | 0.6 g | — |
| Subject | Clarithromycin | Small molecule | 0.5 g | — |
| Subject | Doxycycline | Small molecule | 0.1 g | — |
| Subject | Levofloxacin | Small molecule | 0.5 g | — |
| Subject | Metronidazole | Small molecule | 0.4 g | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |
| Comparator | Tetracycline | Unknown | 0.5 g | — |